Impact of Sonifilan on the Quality of Life in Patients With Cervical Cancer During Radiation or Chemoradiation Therapy

• Status: Recruiting
• Trial end date: 2025-12-01
• Target enrollment: 0
• Participant gender: Female

Summary

The impact of sonifilan on the quality of life in patients with cervical cancer during radiation or chemoradiation therapy

1. Primary endpoint : Quality of life

2. Secondary endpoint : complications related to Sonifilan, treatment effect of Sonifilan

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Asan Medical Center
• Treatments: Sizofiran

Criteria

Inclusion Criteria:

• Cervical cancer FIGO stage IA2 - IVA

• Histologic type : SCC, Adenocarcinoma, Adenosquamous carcinoma

• GOG performance status 0-2

Exclusion Criteria:

• past radiation therapy history

• Neuroendocrine carcinoma

• concurrent other cancer

• uncontrolled medical disease

• ulcerative disease history

• current pregnancy and lactation